On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

OTOA

otoancorin

Chromosome 16p12.2 HGNC:16378 Tier C
OTOA 16p12.2 p arm q arm 16

OTOA is located on the short (p) arm of chromosome 16, at band 16p12.2. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 16 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

OTOA is located on chromosome 16 and encodes otoancorin, a glycoprotein found exclusively in the inner ear. Otoancorin is a structural component of the tectorial and otoconial membranes-acellular structures that play crucial roles in converting mechanical sound waves into electrical signals and maintaining balance. The protein anchors these membranes to the underlying sensory epithelium, ensuring proper transmission of mechanical stimuli to hair cells. Research suggests that otoancorin's unique composition and localisation make it integral to the biomechanical properties of inner ear membranes, which must respond precisely to vibrations and gravitational forces.

What the gene does

Otoancorin functions as an attachment protein within the extracellular matrices of the inner ear. In the cochlea, it forms part of the tectorial membrane, which overlies the organ of Corti and contacts the stereocilia of outer hair cells. This contact is essential for the mechanical deflection of stereocilia during sound transduction. In the vestibular system, otoancorin is present in the otoconial membrane, where it helps anchor calcium carbonate crystals that respond to head movements and gravity. The protein's glycosylation and potential interactions with other matrix components are thought to influence the stiffness and attachment properties of these membranes. Evidence suggests that otoancorin's structural role is critical during both development and maintenance of inner ear function throughout life, as the membranes must retain their precise mechanical characteristics for accurate sensory processing.

Video: Genetics 101

Chromosome location

OTOA is located at chromosomal band 16p12.2 on the short arm of chromosome 16. The gene spans a region of genomic DNA that encodes a transcript producing the otoancorin protein. Specific details regarding exon count and alternative splicing have not been fully characterised in publicly available databases. The genomic context of 16p12.2 places OTOA among other genes, though its expression pattern is notably restricted to inner ear tissues, reflecting its specialised function.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein. Otoancorin is predicted to be a large glycoprotein, and structural studies suggest it contains regions that facilitate protein-protein interactions and membrane attachment. The precise organisation of functional motifs within the amino acid sequence remains an area of ongoing investigation. Post-translational modifications, particularly glycosylation, are likely important for the protein's role in extracellular matrix assembly and stability.

Key variants

Genetic variants in OTOA have been identified in individuals with hearing and balance disorders. These changes range from single nucleotide substitutions to larger deletions that may disrupt protein production or function. The inheritance pattern of OTOA-related conditions can vary, with both recessive and dominant forms reported in different populations. Pathogenic variants may impair otoancorin's ability to anchor inner ear membranes, leading to structural abnormalities that compromise sensory transduction. The clinical presentation and severity can differ depending on the specific variant and its effect on protein stability or localisation.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for OTOA.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
g.21726524del
Deletion
- Pathogenic/Likely pathogenic ★★☆☆ OTOA-related disorder
c.1633_1634del
Microsatellite
p.Leu545fs Pathogenic/Likely pathogenic ★★☆☆ Autosomal recessive nonsyndromic hearing loss 22
c.1765del
Deletion
p.Gln589fs Pathogenic ★★☆☆ Rare genetic deafness
c.2102del
Deletion
p.Ile701fs Pathogenic ★★☆☆ not provided
c.335del
Deletion
p.Lys112fs Pathogenic ★★☆☆ Monogenic hearing loss
c.399+2T>C
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ OTOA-related disorder
c.436C>T
single nucleotide variant
p.Arg146Ter Pathogenic/Likely pathogenic ★★☆☆ OTOA-related disorder
c.442C>T
single nucleotide variant
p.Arg148Ter Pathogenic ★★☆☆ not provided
c.562_569dup
Duplication
p.Phe191fs Pathogenic/Likely pathogenic ★★☆☆ Autosomal recessive nonsyndromic hearing loss 22
c.635+2T>A
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Autosomal recessive nonsyndromic hearing loss 22

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Changes in OTOA are associated with hearing impairment and vestibular dysfunction, though the gene is not currently linked to named conditions in major disease databases. Research into OTOA-related phenotypes continues to expand, with studies describing families affected by sensorineural hearing loss or balance difficulties. The rarity of well-characterised OTOA variants means that genotype-phenotype correlations are still being established. Clinical features may include progressive or congenital hearing loss, and in some cases, vestibular symptoms such as dizziness or imbalance. Further research is needed to fully delineate the spectrum of OTOA-associated disorders.

No disease links recorded for this gene in our reference set.

UK clinical status

Green-listed
High evidence · clinically actionable in NHS testing
Included in NHS GMS signed-off panels

Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory

Frequently asked questions

What does the OTOA gene do?

OTOA encodes otoancorin, a protein that anchors specialised membranes in the inner ear to the underlying sensory tissue. These membranes are essential for detecting sound and maintaining balance by transmitting mechanical forces to sensory hair cells.

How are OTOA variants inherited?

The inheritance pattern of OTOA-related conditions can vary. Some variants follow a recessive pattern, meaning two altered copies are needed for symptoms to occur, while others may show dominant inheritance. Genetic counselling can clarify family-specific risks.

Are OTOA variants common?

Pathogenic variants in OTOA are rare. The gene's highly specialised role in inner ear function means that clinically significant changes are infrequently identified in the general population, though they may be more prevalent in certain families or communities with founder effects.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .